Table 2.
Low risk | Limited data | Not recommended | Contraindicated |
Oral mesalamine | Olsalazine | Tetracycline | Methotrexate |
Topical mesalamine | Infliximab | Sulfonamides | Cyclosporine |
Sulfasalazine | Adalimumab | Azathioprine | |
Corticosteroids | 6-Mercaptopurine | ||
Loperamide | |||
Metronidazole | |||
Ciprofloxacin |